Brief: Pulse Biosciences Announces Strategic Alignment To Accelerate Cardiac Catheter Program Following Exceptional Long-Term Afib Clinical Data
17/03/2026 11:53
March 17 (Reuters) - Pulse Biosciences Inc PLSE.O: PULSE BIOSCIENCES ANNOUNCES STRATEGIC ALIGNMENT TO ACCELERATE CARDIAC CATHETER PROGRAM FOLLOWING EXCEPTIONAL LONG-TERM AFIB CLINICAL DATA Source text: ID:nBw7n96HQa Further company coverage: PLSE.O ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Pulse Biosciences
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Pulse Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Pulse Biosciences Q2 net loss widens, cash position strengthens
Pulse Biosciences Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants